These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 9075729

  • 1. Dual label in situ hybridization studies provide evidence that luteinizing hormone-releasing hormone neurons do not synthesize messenger ribonucleic acid for mu, kappa, or delta opiate receptors.
    Sannella MI, Petersen SL.
    Endocrinology; 1997 Apr; 138(4):1667-72. PubMed ID: 9075729
    [Abstract] [Full Text] [Related]

  • 2. Effects of estrogen and progesterone on luteinizing hormone-releasing hormone messenger ribonucleic acid levels: consideration of temporal and neuroanatomical variables.
    Petersen SL, McCrone S, Keller M, Shores S.
    Endocrinology; 1995 Aug; 136(8):3604-10. PubMed ID: 7628399
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study.
    Peckys D, Landwehrmeyer GB.
    Neuroscience; 1999 Aug; 88(4):1093-135. PubMed ID: 10336124
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Glutamatergic signaling through the N-methyl-D-aspartate receptor directly activates medial subpopulations of luteinizing hormone-releasing hormone (LHRH) neurons, but does not appear to mediate the effects of estradiol on LHRH gene expression.
    Ottem EN, Godwin JG, Petersen SL.
    Endocrinology; 2002 Dec; 143(12):4837-45. PubMed ID: 12446611
    [Abstract] [Full Text] [Related]

  • 10. Opioid receptor gene expression in the rat brain during ontogeny, with special reference to the mesostriatal system: an in situ hybridization study.
    Georges F, Normand E, Bloch B, Le Moine C.
    Brain Res Dev Brain Res; 1998 Aug 08; 109(2):187-99. PubMed ID: 9729374
    [Abstract] [Full Text] [Related]

  • 11. Effect of immune and metabolic challenges on the luteinizing hormone-releasing hormone neuronal system in cycling female rats: an evaluation at the transcriptional level.
    Nappi RE, Rivest S.
    Endocrinology; 1997 Apr 08; 138(4):1374-84. PubMed ID: 9075691
    [Abstract] [Full Text] [Related]

  • 12. Cellular expression of V1a vasopressin receptor mRNA in the female rat preoptic area: effects of oestrogen.
    Kalamatianos T, Kalló I, Goubillon ML, Coen CW.
    J Neuroendocrinol; 2004 Jun 08; 16(6):525-33. PubMed ID: 15189327
    [Abstract] [Full Text] [Related]

  • 13. Characterization of functional opioid delta receptors in a luteinizing hormone-releasing hormone-producing neuronal cell line.
    Maggi R, Pimpinelli F, Martini L, Piva F.
    Endocrinology; 1995 Jan 08; 136(1):289-95. PubMed ID: 7828543
    [Abstract] [Full Text] [Related]

  • 14. Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA.
    Ruzicka BB, Fox CA, Thompson RC, Meng F, Watson SJ, Akil H.
    Brain Res Mol Brain Res; 1995 Dec 28; 34(2):209-20. PubMed ID: 8750824
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression of functional estrogen receptors and galanin messenger ribonucleic acid in immortalized luteinizing hormone-releasing hormone neurons: estrogenic control of galanin gene expression.
    Shen ES, Meade EH, Pérez MC, Deecher DC, Negro-Vilar A, López FJ.
    Endocrinology; 1998 Mar 28; 139(3):939-48. PubMed ID: 9492023
    [Abstract] [Full Text] [Related]

  • 17. Presence of mu and kappa opioid receptor mRNAs in galanin but not in GnRH neurons in the female rat.
    Mitchell V, Prevot V, Jennes L, Aubert JP, Croix D, Beauvillain JC.
    Neuroreport; 1997 Sep 29; 8(14):3167-72. PubMed ID: 9331935
    [Abstract] [Full Text] [Related]

  • 18. Ovarian steroids directly alter luteinizing hormone (LH) release by pituitary homografts.
    McLean BK, Chang N, Nikitovitch-Winer MB.
    Endocrinology; 1975 Jul 29; 97(1):196-201. PubMed ID: 1095356
    [Abstract] [Full Text] [Related]

  • 19. Alterations in opioid parameters in the hypothalamus of rats with estradiol-induced polycystic ovarian disease.
    Desjardins GC, Beaudet A, Brawer JR.
    Endocrinology; 1990 Dec 29; 127(6):2969-76. PubMed ID: 2174340
    [Abstract] [Full Text] [Related]

  • 20. Age-related differences in the sensitivity of serum luteinizing hormone to prototypic mu, kappa and delta opiate agonists and antagonists.
    Cicero TJ, Meyer ER, Miller BT, Bell RD.
    J Pharmacol Exp Ther; 1988 Jul 29; 246(1):14-20. PubMed ID: 2839658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.